Three research projects led by researchers from IDIAPJGol have received funding from the HealthCare Research 2026 call by the "la Caixa" Foundation. These include the integrated care model for people with chronic and complex wounds in Primary Care Metropolitan South and Penedès (UFECAP); the ODISSEA project to prevent mental health stigma in primary care centers, and HH-NICU, an initiative focused on improving family hand hygiene to prevent infections among newborns admitted to neonatal intensive care units.
IDIAPJGol also participates in another funded project, named PAVE, led by the Catalan Institute of Oncology, which aims to develop a screening system for cervical cancer using artificial intelligence. The grants were announced on October 15, 2026, at an event held at CosmoCaixa in Barcelona.
The UFECAP project has funding of 145,200 euros; ODISSEA, 80,000 euros, and HH-NICU, 79,043 euros. The PAVE project receives approximately 299,988 euros.
The UFECAP project, led by Miguel Ángel Díaz, will evaluate the impact of an integrated care model for individuals with chronic and complex wounds in Primary Care Metropolitan South and Penedès. This model relies on advanced practice nurses and professional coordination, utilizing real clinical data from SIDIAP.
The ODISSEA project, led by Laia Gené and Enric Aragonès, aims to improve mental health care in primary care centers through a training intervention to reduce biases in patient care. The 24-month pilot study will be conducted in at least six centers in Catalonia with the participation of the association ObertaMent.
The HH-NICU initiative, led by Anna Bordas, seeks to enhance hand hygiene among relatives and visitors in neonatal intensive care units to prevent infections. The intervention will combine practical training with the use of fluorescent gel and ultraviolet light.
The PAVE project, led by the ICO and with participation from Clara Grau and Betlem Salvador from IDIAPJGol, focuses on improving early detection of cervical cancer through self-sampling, human papillomavirus (HPV) genotyping, and artificial intelligence-assisted analysis.
The HealthCare Research 2026 call supports studies aimed at designing, testing, and evaluating healthcare interventions in real-world settings, with the goal of improving healthcare delivery.
